(Q43551295)

24 November 2017

title

Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients (English)

1 reference

24 November 2017

1 reference

3

H W Sollinger

1 reference

24 November 2017

J M Kovarik

1

1 reference

24 November 2017

M D Pescovitz

2

1 reference

24 November 2017

B Kaplan

4

1 reference

24 November 2017

C Legendre

5

1 reference

24 November 2017

K Salmela

6

1 reference

24 November 2017

B K Book

7

1 reference

24 November 2017

C Gerbeau

8

1 reference

24 November 2017

D Girault

9

1 reference

24 November 2017

K Somberg

10

1 reference

24 November 2017

Simulect Phase IV Sudy group

11

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

published in

Clinical Transplantation

1 reference

24 November 2017

volume

15

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

123-130

1 reference

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

Constructing a prediction interval for time to reach a threshold concentration based on a population pharmacokinetic analysis: an application to basiliximab in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

The effect of azathioprine on gammaglobulin synthesis in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

7 January 2021

Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

7 January 2021

Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

7 January 2021

Suppression of the humoral immune response by mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0012.2001.150208.X

7 January 2021

10.1034/J.1399-0012.2001.150208.X

Identifiers

DOI

1 reference

24 November 2017

1 reference